| SPDR S&P Biotech ETF | (NY: XBI) |
|
104.73 USD
-1.39 (-1.31%)
|
| View: | Quote | Chart | Options | News | Fund Documents |
|
Fund Overview
Quote
Performance
|
Chart
Charting
Compare to:
Top Buys by Directors: Chase's $385K Bet on SRPT
Today 15:08 EDT
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... Read More
from Market News Video
Bullish Two Hundred Day Moving Average Cross - EXEL
June 18, 2013
In trading on Tuesday, shares of Exelixis Inc (EXEL) crossed above their 200 day moving average of $4.78, changing hands as high as $4.82 per share. Exelixis Inc shares are currently trading up about... Read More
from Market News Video
|
Top News
More News
Genome Research Benefits Growing, Getting Cheaper
June 16, 2013
Biotech and drug companies say the benefits of genome research are on the way, and just as importantly, advances are pushing the technology toward affordability. Read More
from CNBC.com News
XBI, AEGR, NPSP, THRX: ETF Inflow Alert
June 14, 2013
Symbols mentioned in this story: XBI, AEGR, NPSP, THRX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
from ETF Channel
Snatch This Deal Even Lower Than Director Marchesi Did
June 12, 2013
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 20, Exelixis Inc's Director, Vincent T. Read More
from Market News Video
MDVN Crosses Above Key Moving Average Level
June 07, 2013
In trading on Friday, shares of Medivation Inc (MDVN) crossed above their 200 day moving average of $51.34, changing hands as high as $52.38 per share. Medivation Inc shares are currently trading up... Read More
from Market News Video
In trading on Wednesday, shares of Halozyme Therapeutics Inc (HALO) crossed below their 200 day moving average of $6.23, changing hands as low as $6.21 per share. Halozyme Therapeutics Inc shares are... Read More
from Market News Video
Two More Weekly LCD Sell Signals
June 05, 2013
The US stock market failed to continue higher after Monday's rebound, and once again, the overseas markets are putting pressure on US stocks in early trading Wednesday. The Nikkei 225 was hit hard... Read More
from Forbes Real Time
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, INFI, ISIS and NVAX
June 03, 2013
from ACCESSWIRE
3 ways to play the biotech boom
June 03, 2013
If you want to join in the biotech boom, these funds offer varying levels of risk and protection, writes Jeff Reeves. Read More
from MarketWatch
In trading on Friday, shares of Achillion Pharmaceuticals Inc. (ACHN) crossed above their 200 day moving average of $8.39, changing hands as high as $8.46 per share. Read More
from Market News Video
Cepheid Enters Oversold Territory (CPHD)
May 31, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
from Market News Video
In trading on Friday, shares of Cepheid (CPHD) crossed below their 200 day moving average of $35.75, changing hands as low as $34.56 per share. Cepheid shares are currently trading down about 3.8% on... Read More
from Market News Video
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
